Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis

BACKGROUND: Hepatocellular carcinoma is a pathological type of liver cancer and accounts for the majority of primary liver cancers. We conducted a meta-analysis to evaluate the efficacy and safety of immune checkpoint inhibitors in combination with antiangiogenic drugs in the treatment of hepatocell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Yu, Huo, Hong, Dai, Shuqi, Li, Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433548/
https://www.ncbi.nlm.nih.gov/pubmed/36059696
http://dx.doi.org/10.3389/fonc.2022.964779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433548/
https://www.ncbi.nlm.nih.gov/pubmed/36059696
http://dx.doi.org/10.3389/fonc.2022.964779

Ejemplares similares